Amgen Inc. (AMGN) fair value analysis
S&P 500 & Nasdaq · Updated 2026-08-30
Forward Fair Value verdict
OvervaluedBased on TickrTrends' weekly Forward Fair Value model, AMGN is trading at more than a 25% premium to estimated fair value.
- Last price
- $432.42
- Sector
- Healthcare
- 12-month range
- $286.92–$385.70
What our data shows for AMGN
- Our model validated 17 trailing price-to-earnings windows for AMGN, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $286.92–$385.70.
- The 14-day relative strength index sits at a neutral 66.
- 3 of the last 12 weekly snapshots showed positive price momentum.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for AMGN
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.